Stockscreener 앱 받기
1.71
3.01%
0.05
Artelo Biosciences Inc 주식(ARTL)의 최신 뉴스
Market Leaders: Is KORE attractive at current valuationJuly 2025 Outlook & Reliable Trade Execution Plans - baoquankhu1.vn
Artelo Biosciences faces new Nasdaq compliance challenges - TipRanks
Artelo Biosciences Received Notice of Noncompliance - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
How Artelo Biosciences Inc. stock reacts to inflationary pressuresDaily Trainer Picks & support options for steady strides - ulpravda.ru
Artelo Biosciences, Inc.Common Stock (NQ: ARTL - FinancialContent
D. Boral Capital Downgrades Artelo Biosciences (ARTL) - MSN
What makes Inno Holdings Inc. stock price move sharply - ulpravda.ru
Can Artelo Biosciences Inc. stock sustain free cash flow growthTrade Volume Report & Free Community Consensus Stock Picks - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Is Artelo Biosciences Inc. stock a buy in volatile marketsJuly 2025 Technicals & Growth Focused Entry Point Reports - Улправда
Star TribuneArtelo Biosciences, Inc.Common Stock (Nasdaq:ARTL) Stock Quote - FinancialContent
How strong is Artelo Biosciences Inc. stock balance sheetCPI Data & Capital Protection Trading Alerts - Улправда
Artelo Biosciences Inc Stock Analysis and ForecastCandlestick Trading Patterns & Best Stocks For Explosive Growth - earlytimes.in
Artelo Biosciences, Inc. (NASDAQ:ARTL) Given Average Recommendation of “Hold” by Analysts - Defense World
Artelo Biosciences adjourns and reschedules 2025 annual meeting - MSN
Bank Watch: Can Artelo Biosciences Inc stock deliver 10 annual returnsQuarterly Market Summary & Reliable Price Breakout Alerts - moha.gov.vn
Is Artelo Biosciences Inc a good long term investmentAI-Driven Market Analysis & Explosive Growth Opportunities - earlytimes.in
Artelo Biosciences adjourns annual meeting due to lack of quorum - Investing.com
Artelo Biosciences Adjourns and Reschedules 2025 Annual Meeting - TipRanks
Artelo Biosciences adjourns annual meeting due to lack of quorum By Investing.com - Investing.com South Africa
Artelo Biosciences Adjourns and Reschedules Annual Meeting - TradingView — Track All Markets
Technical Analysis: How strong is Artelo Biosciences Inc stock balance sheetQuarterly Profit Report & Scalable Portfolio Growth Ideas - Bộ Nội Vụ
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate - The Manila Times
Artelo Biosciences launches public offering; shares down 10% - MSN
Why Artelo Biosciences Inc. stock is favored by top institutionsTrade Volume Report & Free Expert Verified Stock Movement Alerts - Улправда
ARTL (Artelo Biosciences) EV-to-OCF : -0.31 (As of Dec. 22, 2025) - GuruFocus
Geopolitics Watch: Why Artelo Biosciences Inc. stock is favored by top institutions2025 Pullback Review & Free Safe Capital Growth Stock Tips - Улправда
Artelo Biosciences launches underwritten public offering to raise capital - MSN
Artelo Biosciences Earnings Notes - Trefis
Mark Edward Spring Net Worth (2025) - GuruFocus
Artelo Biosciences files to sell 899,972 shares of common stock for holders - MSN
Artelo Biosciences, Inc. (ARTL) 6.68% in After-hours: Following Strong Business Update - Stocks Telegraph
Artelo Biosciences Revises Bylaws, Alters Governance Structure - MSN
Artelo Biosciences (ARTL) Stock: Faces Market Reaction After Positive Research on Stress Relief Treatments - parameter.io
Unexpected Movements: Artelo Biosciences’ Stock Dynamics - timothysykes.com
Artelo Biosciences (ARTL) Research Highlights Potential of FABP5 Inhibitor in Stress Management - GuruFocus
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of A Novel Fatty Acid Binding Protein 5 Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical Mod - marketscreener.com
Artelo (Nasdaq: ARTL) study: FABP5 inhibitor reduces anxiety, depression in rats - Stock Titan
Artelo Biosciences, Inc. (ARTL) -5.56% in After-hours: Stock Declines Amid Routine Trading - Stocks Telegraph
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Will Artelo Biosciences Inc. stock see insider buyingJobs Report & AI Driven Stock Movement Reports - Newser
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
What's going on in today's after hours session - Chartmill
What analysts say about Artelo Biosciences Inc stockMACD Histogram Signals & Target Triple-Digit Stock Opportunities - earlytimes.in
Artelo Biosciences Appeals Nasdaq Delisting Decision - MSN
Artelo Biosciences (NASDAQ:ARTL) Given “Hold” Rating at Maxim Group - Defense World
Artelo Biosciences Inc. stock trend forecast2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Regression analysis insights on Artelo Biosciences Inc. performance - newser.com
Published on: 2025-11-19 14:48:52 - newser.com
Analyzing net buyer seller activity in Artelo Biosciences Inc.2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
ARTL Stock Downgraded to Hold by Maxim Group | ARTL Stock News - GuruFocus
Applying Wyckoff theory to Artelo Biosciences Inc. stockMarket Performance Recap & Verified Technical Trade Signals - newser.com
Will Artelo Biosciences Inc. outperform the marketQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Maxim Downgrades Artelo Biosciences to Hold From Buy - MarketScreener
4.73%
0.92%
자본화:
|
볼륨(24시간):